What steps are companies taking to help curb AMR by manufacturing responsibly?

  23 August 2023

It is becoming increasingly clear that releasing antibiotic waste into the environment can drive antimicrobial resistance (AMR). In helping to curb this rapidly rising global health threat, pharmaceutical companies can ensure the production of their lifesaving antibiotics does not inadvertently contribute to drug resistance. A new report from the Foundation zeroes in on this issue, setting out three key areas pharmaceutical companies can focus on to ensure they limit AMR risk from manufacturing more effectively.

Author(s): Access to Medicine Foundation
Clean Environment  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed